Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Comparison Of The Attitudes About Legalization Of Marijuana Use For Medical Purposes By Cancer Patients In Two Cancer Centers Located In A Legalized And A Non-Legalized State

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03360799
Recruitment Status : Active, not recruiting
First Posted : December 4, 2017
Last Update Posted : August 6, 2018
Sponsor:
Information provided by (Responsible Party):
M.D. Anderson Cancer Center

Brief Summary:

The goal of this research study is to learn about and compare the attitudes that patients in non-legalized and legalized states have towards the legalization of medical marijuana.

This is an investigational study.

Up to 202 participants will be enrolled in this study. Up to 102 will take part at MD Anderson.


Condition or disease Intervention/treatment
Malignant Neoplasms of Independent (Primary) Multiple Sites Behavioral: Questionnaires

Detailed Description:

If you choose to take part in this study, you will complete 5 questionnaires which will ask for your demographic information (age, race, sex, and so on) and about your feelings towards doctors, the use of marijuana (including your own personal use), any religious or spiritual feelings that you may have, and about any anxiety and depression you may have experienced. These should take about 20-25 minutes to complete. You may complete the questionnaires on a hard copy survey or electronically on a tablet provided by the research staff. Surveys will not be e-mailed to you.

If you are unable to complete the study questionnaires during this clinic visit, you will be called by the research coordinator to complete them within 1 week. Your phone number will be collected to contact you and will be deleted after you complete the questionnaires.

All questionnaire responses will be anonymous. No personally identifying information will be linked to your responses.

Your participation on this study will be over after you complete the questionnaires.


Layout table for study information
Study Type : Observational
Actual Enrollment : 101 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: A Comparison Of The Attitudes About Legalization Of Marijuana Use For Medical Purposes By Cancer Patients In Two Cancer Centers Located In A Legalized And A Non-Legalized State
Actual Study Start Date : November 17, 2017
Estimated Primary Completion Date : July 2019
Estimated Study Completion Date : July 2019

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Marijuana

Group/Cohort Intervention/treatment
Medical Marijuana Questionnaire
Participants (inpatient or outpatient) seen by the Palliative Care team at Banner MD Anderson or UT MD Anderson.
Behavioral: Questionnaires
Participants complete 5 questionnaires which ask for demographic information (age, race, sex, and so on) and about participants feelings towards doctors, the use of marijuana (including participant's own personal use), any religious or spiritual feelings that participant may have, and about any anxiety and depression participant may have experienced. These should take about 20-25 minutes to complete.
Other Name: Surveys




Primary Outcome Measures :
  1. Proportion of Cancer Participants Who Have a Positive Attitude About Legalizing Marijuana for Medical Purposes [ Time Frame: 1 day ]
    Number of subjects with positive attitude towards legalizing medical marijuana compared between participants from Texas and Arizona States using one-sided Fisher's exact test or chi-squared test.


Secondary Outcome Measures :
  1. Evaluation of Participant's Belief in the Usefulness of Medical Marijuana [ Time Frame: 1 day ]

    Participant's belief in the usefulness of medical marijuana evaluated between those who are residents of Texas versus Arizona.

    Objective addressed by evaluating question 5 in the Marijuana Survey for Patients. Those who answer "Completely Agree" or "Slightly Agree" considered as positive believers. The proportion of patients with positive belief reported with a 95% confidence interval. Fisher's exact test applied to compare the proportion between residents of two states.




Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Participants (inpatient or outpatient) seen by the Palliative Care team at Banner MD Anderson or UT MD Anderson.
Criteria

Inclusion Criteria:

  1. Patients (inpatient or outpatient) seen by the Palliative Care team at Banner MD Anderson or UT MD Anderson.
  2. Patients able to speak and read English.
  3. Patients are 18 years old and above.
  4. Patients enrolled in each site must be a resident of the state where that site is located (e.g. if a patient is enrolled at UT MDACC, they should be resident of the state of Texas).
  5. Patients should have a cancer diagnosis.

Exclusion Criteria:

  1. Patients who are not able to speak or read English.
  2. Altered mental status as determined by the interviewer based on the ability to understand the nature of the study and consent process.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03360799


Locations
Layout table for location information
United States, Arizona
Banner MD Anderson Cancer Center
Gilbert, Arizona, United States, 85234
United States, Texas
University of Texas MD Anderson Cancer Center
Houston, Texas, United States, 77030
Sponsors and Collaborators
M.D. Anderson Cancer Center
Investigators
Layout table for investigator information
Principal Investigator: Kimberson C. Tanco, MD M.D. Anderson Cancer Center

Additional Information:
Layout table for additonal information
Responsible Party: M.D. Anderson Cancer Center
ClinicalTrials.gov Identifier: NCT03360799     History of Changes
Other Study ID Numbers: 2017-0568
NCI-2018-01026 ( Registry Identifier: NCI CTRP )
First Posted: December 4, 2017    Key Record Dates
Last Update Posted: August 6, 2018
Last Verified: August 2018

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Keywords provided by M.D. Anderson Cancer Center:
Malignant neoplasms of independent (primary) multiple sites
Questionnaires
Surveys

Additional relevant MeSH terms:
Layout table for MeSH terms
Neoplasms
Marijuana Use
Substance-Related Disorders
Mental Disorders